Immune checkpoint inhibitor combinations: Current efforts and important aspects for success

Edo Kon(Tel Aviv University), Itai Benhar(Tel Aviv University)

Drug Resistance Updates

July 1, 2019

10.1016/j.drup.2019.07.004

Cited by 122

Abstract

Related Papers

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Glen Dranoff, Elizabeth M. Jaffee, A Lazenby et al.|Proceedings of the National Academy of Sciences|1993|2.8k

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

Christina Twyman-Saint Victor, Andrew J. Rech, Amit Maity et al.|Nature|2015|2.4k

Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack

Chamutal Gur, Yara Ibrahim, Batya Isaacson et al.|Immunity|2015|1.4k

Role of Tyrosine Kinase Inhibitors in Cancer Therapy

Amit Arora, Eric Scholar|Journal of Pharmacology and Experimental Therapeutics|2005|1k

Assessment of the Evolution of Cancer Treatment Therapies

Manuel Arruebo, Nuria Vilaboa, Berta Sáez et al.|Cancers|2011|910